Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graham P Taylor

Showing results (161-170 of 227) with videos related to

Pageof 23
Sort By:
Frontiers in Cellular and Infection Microbiology|March 1, 2021
<i>Lactobacillus</i>-Depleted Vaginal Microbiota in Pregnant Women Living With HIV-1 Infection Are Associated With Increased Local Inflammation and Preterm BirthCharlotte-Eve S Short, Richard G Brown, Rachael Quinlan, et al.
The Journal of Infectious Diseases|June 8, 2004
Human T cell lymphotropic virus (HTLV) type-1-specific CD8+ T cells: frequency and immunodominance hierarchyPeter K C Goon, Alix Biancardi, Noam Fast, et al.
Blood|February 1, 2003
Low frequency of CD94/NKG2A+ T lymphocytes in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis, but not in asymptomatic carriersMineki Saito, Veronique M Braud, Peter Goon, et al.
The Journal of Infectious Diseases|August 23, 2013
T-cell immunophenotyping distinguishes active from latent tuberculosisKatrina M Pollock, Hilary S Whitworth, Damien J Montamat-Sicotte, et al.
Frontiers in Cellular and Infection Microbiology|December 16, 2021
Vaginal Microbiota, Genital Inflammation and Extracellular Matrix Remodelling Collagenase: MMP-9 in Pregnant Women With HIV, a Potential Preterm Birth Mechanism Warranting Further ExplorationCharlotte-Eve S Short, Rachael A Quinlan, Xuan Wang, et al.
Blood|March 15, 2011
Kinetics and intracellular compartmentalization of HTLV-1 gene expression: nuclear retention of HBZ mRNAsFrancesca Rende, Ilaria Cavallari, Alberto Corradin, et al.
Journal of Neurovirology|February 2, 2021
Association between high proviral load, cognitive impairment, and white matter brain lesions in HTLV-1-infected individualsRosangela Souza Kalil, Isabelle Vasconcellos, Carolina Rosadas, et al.
Pilot and Feasibility Studies|December 15, 2016
Timed walk as primary outcome measure of treatment response in clinical trials for HTLV-1-associated myelopathy: a feasibility studyFabiola Martin, Eisuke Inoue, Irene C M Cortese, et al.
Plos Neglected Tropical Diseases|June 22, 2012
Ciclosporin A proof of concept study in patients with active, progressive HTLV-1 associated myelopathy/tropical spastic paraparesisFabiola Martin, Hannah Castro, Carolyn Gabriel, et al.
Retrovirology|September 21, 2006
Zidovudine plus lamivudine in Human T-Lymphotropic Virus type-I-associated myelopathy: a randomised trialGraham P Taylor, Peter Goon, Yoshitaka Furukawa, et al.
Pageof 23

Showing results (161-170 of 227) with videos related to

Sort By:
Pageof 23
Frontiers in Cellular and Infection Microbiology|March 1, 2021
<i>Lactobacillus</i>-Depleted Vaginal Microbiota in Pregnant Women Living With HIV-1 Infection Are Associated With Increased Local Inflammation and Preterm BirthCharlotte-Eve S Short, Richard G Brown, Rachael Quinlan, et al.
The Journal of Infectious Diseases|June 8, 2004
Human T cell lymphotropic virus (HTLV) type-1-specific CD8+ T cells: frequency and immunodominance hierarchyPeter K C Goon, Alix Biancardi, Noam Fast, et al.
Blood|February 1, 2003
Low frequency of CD94/NKG2A+ T lymphocytes in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis, but not in asymptomatic carriersMineki Saito, Veronique M Braud, Peter Goon, et al.
The Journal of Infectious Diseases|August 23, 2013
T-cell immunophenotyping distinguishes active from latent tuberculosisKatrina M Pollock, Hilary S Whitworth, Damien J Montamat-Sicotte, et al.
Frontiers in Cellular and Infection Microbiology|December 16, 2021
Vaginal Microbiota, Genital Inflammation and Extracellular Matrix Remodelling Collagenase: MMP-9 in Pregnant Women With HIV, a Potential Preterm Birth Mechanism Warranting Further ExplorationCharlotte-Eve S Short, Rachael A Quinlan, Xuan Wang, et al.
Blood|March 15, 2011
Kinetics and intracellular compartmentalization of HTLV-1 gene expression: nuclear retention of HBZ mRNAsFrancesca Rende, Ilaria Cavallari, Alberto Corradin, et al.
Journal of Neurovirology|February 2, 2021
Association between high proviral load, cognitive impairment, and white matter brain lesions in HTLV-1-infected individualsRosangela Souza Kalil, Isabelle Vasconcellos, Carolina Rosadas, et al.
Pilot and Feasibility Studies|December 15, 2016
Timed walk as primary outcome measure of treatment response in clinical trials for HTLV-1-associated myelopathy: a feasibility studyFabiola Martin, Eisuke Inoue, Irene C M Cortese, et al.
Plos Neglected Tropical Diseases|June 22, 2012
Ciclosporin A proof of concept study in patients with active, progressive HTLV-1 associated myelopathy/tropical spastic paraparesisFabiola Martin, Hannah Castro, Carolyn Gabriel, et al.
Retrovirology|September 21, 2006
Zidovudine plus lamivudine in Human T-Lymphotropic Virus type-I-associated myelopathy: a randomised trialGraham P Taylor, Peter Goon, Yoshitaka Furukawa, et al.
Pageof 23